share_log

Longeveron Shares Move Slightly Higher; Co. Issues PR Highlighting News From Friday The Company Was Granted Orphan Drug Designation By FDA For Lomecel-B To Treat Infants With Hypoplastic Left Heart Syndrome

Longeveron Shares Move Slightly Higher; Co. Issues PR Highlighting News From Friday The Company Was Granted Orphan Drug Designation By FDA For Lomecel-B To Treat Infants With Hypoplastic Left Heart Syndrome

Longeveron公司股价小幅走高;公司发布公关消息周五消息该公司获得FDA授予的Lomecel-B孤儿药物指定,用于治疗患有左心发育不良综合征的婴儿
Benzinga Real-time News ·  2021/12/06 08:11

Longeveron Shares Move Slightly Higher; Co. Issues PR Highlighting News From Friday The Company Was Granted Orphan Drug Designation By FDA For Lomecel-B To Treat Infants With Hypoplastic Left Heart Syndrome

Longeveron公司股价小幅走高;公司发布公关消息周五消息该公司获得FDA授予的Lomecel-B孤儿药物指定,用于治疗患有左心发育不良综合征的婴儿

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发